Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat

被引:101
作者
Lenz, EM
Bright, J
Knight, R
Westwood, FR
Davies, D
Major, H
Wilson, ID
机构
[1] AstraZeneca, Dept Drug Metab & Pharmacokinet, Macclesfield SK10 4TG, Cheshire, England
[2] AstraZeneca, Global Sci & Informat, Macclesfield SK10 4TG, Cheshire, England
[3] AstraZeneca, Safety Assessment, Macclesfield SK10 4TG, Cheshire, England
[4] Waters Corp, Manchester, Lancs, England
关键词
metabonomics; nephrotoxicity; pattern recognition; gentamicin;
D O I
10.1080/13547500500094034
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The model nephrotoxin gentamicin was administered to male Wistar-derived rats daily, for 7 days, at 60 mg kg(-1) day(-1), subcutaneously, twice daily. Conventional clinical chemistry urinalysis showed a significant increase in N-acetyl-beta-D-glucosaminidase ( NAG) activity from day 3. At necropsy on day 9, clear histological damage to the kidney was noted with all animals showing a generally severe nephropathy primarily focused on the proximal convoluted tubules. The urinary excretion pattern of endogenous metabolites over the time course of the study was studied using a combination of H-1-NMR spectroscopy and HPLC-TOF-MS/MS using electrospray ionization (ESI). Changes in the pattern of endogenous metabolites as a result of daily administration of gentamicin were readily detected by both techniques with significant perturbations of the urinary profile observed from day 7 onwards. The findings by H-1-NMR included raised glucose and reduced trimethylamine N-oxide ( TMAO). Changes in metabonomic profiles were observed by HPLC-MS in both positive and negative ESI. The MS data showed reduced xanthurenic acid and kynurenic acid, whilst neutral loss experiments also revealed a changed pattern of sulphate conjugation on gentamicin administration.
引用
收藏
页码:173 / 187
页数:15
相关论文
共 18 条
  • [1] ANTHONY ML, 1994, MOL PHARMACOL, V46, P199
  • [2] Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins
    Beckwith-Hall, BM
    Nicholson, JK
    Nicholls, AW
    Foxall, PJD
    Lindon, JC
    Connor, SC
    Abdi, M
    Connelly, J
    Holmes, E
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (04) : 260 - 272
  • [3] Nuclear magnetic resonance and high-performance liquid chromatography nuclear magnetic resonance studies on the toxicity and metabolism of ifosfamide
    Foxall, PJD
    Lenz, EM
    Lindon, JC
    Neild, GH
    Wilson, ID
    Nicholson, JK
    [J]. THERAPEUTIC DRUG MONITORING, 1996, 18 (04) : 498 - 505
  • [4] GARTLAND KPR, 1989, MOL PHARMACOL, V35, P242
  • [5] Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra
    Holmes, E
    Antti, H
    [J]. ANALYST, 2002, 127 (12) : 1549 - 1557
  • [6] Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis
    Idborg-Björkman, H
    Edlund, PO
    Kvalheim, OM
    Schuppe-Koistinen, I
    Jacobsson, SP
    [J]. ANALYTICAL CHEMISTRY, 2003, 75 (18) : 4784 - 4792
  • [7] Metabolite profiling in rat urine by liquid chromatography/electrospray ion trap mass spectrometry. Application to the study of heavy metal toxicity
    Lafaye, A
    Junot, C
    Ramounet-Le Gall, B
    Fritsch, P
    Tabet, JC
    Ezan, E
    [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2003, 17 (22) : 2541 - 2549
  • [8] Cyclosporin A-induced changes in endogenous meta-bolites in rat urine:: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics
    Lenz, EM
    Bright, J
    Knight, R
    Wilson, ID
    Major, H
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (03) : 599 - 608
  • [9] A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS:: time dependant changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity
    Lenz, EM
    Bright, J
    Knight, R
    Wilson, ID
    Major, H
    [J]. ANALYST, 2004, 129 (06) : 535 - 541
  • [10] Contemporary issues in toxicology - The role of metabonomics in toxicology and its evaluation by the COMET project
    Lindon, JC
    Nicholson, JK
    Holmes, E
    Antti, H
    Bollard, ME
    Keun, H
    Beckonert, O
    Ebbels, TM
    Reilly, MD
    Robertson, D
    Stevens, GJ
    Luke, P
    Breau, AP
    Cantor, GH
    Bible, RH
    Niederhauser, U
    Senn, H
    Schlotterbeck, G
    Sidelmann, UG
    Laursen, SM
    Tymiak, A
    Car, BD
    Lehman-McKeeman, L
    Colet, JM
    Loukaci, A
    Thomas, C
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 187 (03) : 137 - 146